Peet N P, Lentz N L, Sunder S, Dudley M W, Ogden A M
Marion Merrell Dow Research Institute, Cincinnati, Ohio 45215.
J Med Chem. 1992 Aug 21;35(17):3263-9. doi: 10.1021/jm00095a024.
Two modes of tethering a chiral (phenylisopropyl)amino substituent in pyrazolo[3,4-d]pyrimidines and purines have been explored. One mode gave (S)-2,7-dihydro-7-phenyl-2-(phenylmethyl)-5- propoxy-3H-imidazo[1,2-c]pyrazolo-[4,3-e]pyrimidine (12a) and its corresponding R-enantiomer 12b, which were selective for A2 and A1 adenosine receptors, respectively. The corresponding diimidazo[1,2-c:4',5'-e]pyrimidines 12e and 12f were analogously selective. This is the first example where a single chiral recognition unit provides enantiomers with opposite selectivities for adenosine receptors. The second mode gave (2S-trans)-2,7-dihydro-2-methyl-3,7-diphenyl-5- propoxy-3H-imidazo[1,2-c]-pyrazolo[4,3-e]pyrimidine (12c) and its corresponding R-enantiomer 12d. Compounds 12c and 12d were significantly less potent than 12a and 12b at A1 receptors, and were nonselective.
研究了在吡唑并[3,4-d]嘧啶和嘌呤中连接手性(苯异丙基)氨基取代基的两种方式。一种方式得到了(S)-2,7-二氢-7-苯基-2-(苯甲基)-5-丙氧基-3H-咪唑并[1,2-c]吡唑并[4,3-e]嘧啶(12a)及其相应的R-对映体12b,它们分别对A2和A1腺苷受体具有选择性。相应的二咪唑并[1,2-c:4',5'-e]嘧啶12e和12f也具有类似的选择性。这是第一个单一手性识别单元为腺苷受体提供具有相反选择性对映体的例子。第二种方式得到了(2S-反式)-2,7-二氢-2-甲基-3,7-二苯基-5-丙氧基-3H-咪唑并[1,2-c]吡唑并[4,3-e]嘧啶(12c)及其相应的R-对映体12d。化合物12c和12d在A1受体上的活性明显低于12a和12b,且无选择性。